What are the fluid requirements in toxic epidermal necrolysis?

Journal of Burn Care and Research

Volumn 31, Issue 1, 2010, Pages 100-104

  Shiga, Sarah ^a   Cartotto, Rob ^a  

^a SUNNYBROOK RESEARCH INSTITUTE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BIOPSY TECHNIQUE; CLINICAL ARTICLE; COLLOID; CONTROLLED STUDY; CORRELATION ANALYSIS; CRYSTALLOID; FEMALE; FLUID BALANCE; HUMAN; MALE; MEDICAL RECORD REVIEW; MORTALITY; RESUSCITATION; SCORING SYSTEM; SURVIVAL RATE; TOXIC EPIDERMAL NECROLYSIS; URINE VOLUME;

ADULT; AGED; BURN UNITS; CLINICAL PROTOCOLS; COHORT STUDIES; COLLOIDS; DOSE-RESPONSE RELATIONSHIP, DRUG; EPIDERMAL NECROLYSIS, TOXIC; FEMALE; FLUID THERAPY; HUMANS; ISOTONIC SOLUTIONS; MALE; MIDDLE AGED; PLASMA SUBSTITUTES; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 75649122523     PISSN: 1559047X     EISSN: 15590488     Source Type: Journal    
DOI: 10.1097/BCR.0b013e3181cb8cb8     Document Type: Article

References (29)

1. Lyell A. Toxic epidermal necrolysis: an eruption resembling scalding of the skin. Br J Dermatol 1956;68:355-361
2. Roujeau JC. Stevens-Johnson syndrome and toxic epidermal necrolysis are severity variants of the same disease which differs from erythema multiforme. J Dermatol 1997;24:726-729
3. Roujeau JC, Kelly JP, Naldi L, et al. Medication use and the risk of Stevens-Johnson syndrome or toxic epidermal necrolysis. N Engl J Med 1995;333:1600-1607
4. Palmieri TL, Greenhalgh DG, Saffle JR, et al. A multicenter review of toxic epidermal necrolysis treated in U.S. burn centers at the end of the twentieth century. J Burn Care Rehabil 2002;23:87-96.
5. Chan HL, Stern RS, Arndt KA, et al. The incidence of erythema multiforme, Stevens-Johnson syndrome, and toxic epidermal necrolysis. A population-based study with particular reference to reactions caused by drugs among outpatients. Arch Dermatol 1990;126:43-47
6. Roujeau JC, Guillaume JC, Fabre JP, et al. Toxic epidermal necrolysis (Lyell syndrome). Incidence and drug etiology in France, 1981-1985. Arch Dermatol 1990;126:37-42.
7. Roujeau JC, Stern RS. Severe adverse cutaneous reactions to drugs. New Engl J Med 1994;331:1272-1285
8. Bastuji-Garin S, Fouchard N, Bertocchi M, et al. SCORTEN: a severity of illness score for toxic epidermal necrolysis. J Investig Derm 2000;115:149-153
9. Bone RC, Balk RA, Cerra FB, et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM consensus conference committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 1992;101:1644-1655
10. Cartotto R, Fish J. Exfoliative disorders of the skin. In: Mathes SJ, Hentz VR, editors. Plastic Surgery. Vol 1. 2nd ed. Philadelphia: Elsevier; 2006. p 793-810.
11. Prins C, Kerdel FA, Padilla RS, et al. Treatment of toxic epidermal necrolysis with high-dose intravenous immunoglobulins: multicenter retrospective analysis of 48 consecutive cases. Arch Dermatol 2003;139:26-32.
12. Shortt R, Gomez M, Mittman N, Cartotto R. Intravenous immunoglobulin does not improve outcome in toxic epidermal necrolysis. J Burn Care Rehabil 2004;25:246-255
13. Hebert PC, Wells G, Blajchman MA, et al. A multicenter randomized controlled clinical trial of transfusion requirements in critical care. New Engl J Med 1999;340:409-417
14. Dellinger R, Carlet J, Masur H, et al. Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock. Crit Care Med 2004;32:858-873 (Pubitemid 38344143)
15. Stella M, Clemente A, Bollero D, Risso D, Dalmasso P. Toxic epidermal necrolysis (TEN) and Stevens-Johnson syndrome (SJS): experience with high-dose intravenous immunoglobulins and topical conservative approach. A retrospective analysis. Burns 2007;33:452-459
16. Spies M, Sanford AP, Aili Low JF, Wolf SE, Herndon DN. Treatment of extensive toxic epidermal necrolysis in children. Pediatrics 2001;108:1162-1168
17. Peters W, Zaidi J, Douglas L. Toxic epidermal necrolysis: a burn-centre challenge. CMAJ 1991;144:1477-1480
18. Taylor JA, Grube B, Heimbach DM, Bergman AB. Toxic epidermal necrolysis. A comprehensive approach. Multidisciplinary management in a burn center. Clin Pediatr 1989;28: 404-407
19. Khoo AK, Foo CL. Toxic epidermal necrolysis in a burns centre: a 6-year review. Burns 1996;22:275-278
20. Revuz J, Roujeau JC, Guillaume JC, Penso D, Touraine R. Treatment of toxic epidermal necrolysis. Creteil's experience. Arch Dermatol 1987;123:1156-1158 (Pubitemid 17119308)
21. Endorf FW, Cancio LC, Gibran NS. Toxic epidermal necrolysis clinical guidelines. J Burn Care Res 2008;29: 706-712
22. Finlay AY, Richards J, Holt PJ. Intensive therapy unit management of toxic epidermal necrolysis: practical aspects. Clin Exp Dermatol 1982;7:55-60.
23. Roujeau JC. Treatment of severe drug eruptions. J Dermatol 1999;26:718-722
24. Saffle JR. The phenomenon of "fluid creep" in acute burn resuscitation. J Burn Care Res 2007;28:382-395
25. Pruitt BA. Protection from excessive resuscitation: "pushing the pendulum back" (Editorial). J Trauma 2000;49:567-568
26. Blumetti J, Hunt JL, Arnoldo BD, Parks JK, Purdue GF. The Parkland formula under fire: is the criticism justified? J Burn Care Res 2008;29:180-186
27. Cancio LC, Chavaz S, Alvarado-Ortega M, et al. Predicting increased fluid requirements during the resuscitation of thermally injured patients. J Trauma 2004;56:404-414
28. Cartotto R, Choi J, Gomez M, Cooper A. A prospective study on the implications of a base deficit during fluid resuscitation. J Burn Care Rehabil 2003;24:75-84.
29. Cochrane A, Edelman LS, Saffle JR, Morris SE. The relationship of serum lactate and base deficit in burn patients to mortality. J Burn Care Res 2007;28:231-240